Digvijay Gaekwad from Florida-based Danny Gaekwad Developments & Investments has made a 17% higher competing offer for Religare shareholders. He is working with a team for compliance and protocol adherence. He believes his offer is fair and will benefit the shareholders, enhancing the company’s value. He has already communicated his plan through regulatory steps.
Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25
Biocon’s board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected
January 30, 2025